PALO ALTO, Calif. and NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Walrus, the decentralized data storage protocol built by Mysten Labs, the original contributors to Sui, and Veea Inc. (Nasdaq:VEEA), a leader in intelligent edge infrastructure, today announced the adoption of Walrus as a VeeaHub STAX™ edge solution to provide high-performance data transport and storage capabilities for the decentralized network.

The presentation will include data from over 90 patients in both the plaque brachytherapy and enucleation-eligible cohorts Darovasertib has received U.S. FDA Breakthrough Therapy Designation for use in neoadjuvant uveal melanoma for subjects requiring enucleation Initiated a multi-site, global randomized Phase 3 neoadjuvant registrational trial in primary uveal melanoma (OptimUM-10) in Q3 2025 SOUTH SAN FRANCISCO, Calif. , July 24, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced that results from a multi-site global Phase 2 study of neoadjuvant darovasertib in primary uveal melanoma was accepted for a Proffered Paper oral presentation …

The S&P 500 enters Thursday trading right where it left off Wednesday night — neither up nor down.

I am bullish on Novo Nordisk due to its 62% global GLP-1 market share and dominant Ozempic sales, supporting long-term leadership. Novo Nordisk's diversified GLP-1 portfolio, including Rybelsus and pending pill versions, positions it well against competitors and broadens its addressable market. Consistent double-digit revenue and profit growth, plus strong Q2 2025 expectations, reflect robust demand and effective cost management.

After a rough start to the year, tech stocks are back on top. As of this writing, the tech-heavy Nasdaq Composite is up 28% over the last three months.

SAN FRANCISCO--(BUSINESS WIRE)--AlikeAudience, a leading data science company specializing in omnichannel data activation, today announced the launch of AURAR, a groundbreaking data collaboration tool, with a native Lookalike model application now available in the Snowflake Marketplace. With AURAR, AlikeAudience is empowering marketers to prepare ideal audiences through seamless, secure, and accelerated collaboration with first-party data. The launch of AURAR addresses the fundamental shifts dr.

Candel Therapeutics Inc (NASDAQ:CADL) announced that the European Medicines Agency (EMA) has granted Orphan Designation to its investigational immunotherapy CAN-2409 for the treatment of pancreatic cancer. The designation adds to CAN-2409's existing Orphan Drug Designation and Fast Track Designation from the US Food and Drug Administration for pancreatic ductal adenocarcinoma.

UnitedHealth Group Inc. (NYSE: UNH) shares tumbled another 4% in premarket trading following the company's disclosure of a Department of Justice investigation into its Medicare program practices, adding to what has already been a disastrous year for the healthcare giant.

Here's our initial take on Novocure's (NVCR -9.99%) fiscal 2025 second-quarter financial report.

U.S. stocks are rising toward more records on Wednesday following a trade deal between the world's No. 1 and No. 4 economies, one that would lower proposed tariffs on Japanese imports coming to the United States.

Raymond James misses fiscal Q3 earnings expectations due to a $58M legal reserve. On the other hand, trading and IB strength help lift revenues.

CRGY, BHB and HII made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 24, 2025.

First Northwest Bancorp (FNWB) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.16 per share a year ago.

Dime Community (DCOM) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.37 per share a year ago.

Genuine Parts Co. offers a reliable, safe dividend and is a Dividend King with 69 years of raises with recent growth beginning again to improve. The stock is currently fairly valued with a P/E near its historical average, just after a good earnings report on July 22, 2025. Strong competitive advantages include a vast distribution network, quality private label parts, and resilience against electric vehicle disruption.

Bowie, MD, July 24, 2025 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator, and provider of electric vehicle (EV) charging equipment and services, will announce its second quarter results on Thursday, August 7, 2025, following the close of the financial markets. The Company will host a conference call and webcast that day at 4:30 p.m. Eastern Time to discuss the Company's results for the second quarter ended June 30, 2025.

The gold market sold off aggressively in the overnight session, as the markets are relaxing a bit about the threat of massive tariff wars. With this, we find gold is in the middle of the larger consolidation area, and therefore, it is a short-term market at the moment.

Imax saw profits surge and revenue rise last quarter as the company beat Wall Street forecasts with global box office up 19% year-on-year and its highest grossing domestic quarter ever at $143 million.

Micron Technology needs the high-bandwidth memory boom to continue. SK Hynix is providing evidence it will.

Alphabet's earnings beat lifts tech stocks, boosting the Nasdaq 100, while IBM drags down the Dow. US indices diverge as investors weigh mixed results.